|
Benefit of mepolizumab for asthma not proven in trials
UPI.com Mepolizumab, sold as Nucala, was not compared fairly against other asthma treatments, raising questions as to whether it has benefits over other drugs already used for the condition, the German Institute for Quality and Efficiency in Health Care said … Mepolizumab in severe asthma: Added benefit not proven |
View full post on asthma – Google News